Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.

Hyun Gul YangMoon Cheol KangTae Yoon KimInjung HwangHyun Tak JinYoung Chul SungKi-Seong EomSae Won Kim

Published in: Journal for immunotherapy of cancer (2019)

NK101 is a unique NK cell line bearing strong immunostimulatory potential and substantial scalability, providing an attractive source for adoptive cancer immunotherapy.

Keyphrases

nk cells
high throughput
small molecule
cell therapy
human health
stem cells
risk assessment
mesenchymal stem cells